The current stock price of SNYR is 1.83 USD. In the past month the price decreased by -13.88%. In the past year, price decreased by -65.84%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EL | ESTEE LAUDER COMPANIES-CL A | 62.85 | 38.05B | ||
| KVUE | KENVUE INC | 16.22 | 33.25B | ||
| ELF | ELF BEAUTY INC | 25.14 | 4.62B | ||
| BRBR | BELLRING BRANDS INC | 15.05 | 3.91B | ||
| COTY | COTY INC-CL A | 17.66 | 2.93B | ||
| IPAR | INTERPARFUMS INC | 15.83 | 2.66B | ||
| OLPX | OLAPLEX HOLDINGS INC | 16.56 | 884.45M | ||
| EPC | EDGEWELL PERSONAL CARE CO | 6.91 | 815.84M | ||
| NUS | NU SKIN ENTERPRISES INC - A | 7.62 | 512.36M | ||
| NATR | NATURES SUNSHINE PRODS INC | 23.43 | 385.35M | ||
| USNA | USANA HEALTH SCIENCES INC | 10.49 | 376.02M | ||
| HNST | HONEST CO INC/THE | 48.09 | 322.58M |
Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company is headquartered in Westbrook, Maine and currently employs 21 full-time employees. The company went IPO on 2013-11-08. The firm is the provider of consumer healthcare, beauty, and lifestyle products. The Company’s brand portfolio consists of FOCUSfactor and Flat Tummy. FOCUSfactor is a brain health supplement brand. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. The company has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications.
SYNERGY CHC CORP
865 Spring St
Westbrook MAINE US
Employees: 21
Phone: 16159399004
Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company is headquartered in Westbrook, Maine and currently employs 21 full-time employees. The company went IPO on 2013-11-08. The firm is the provider of consumer healthcare, beauty, and lifestyle products. The Company’s brand portfolio consists of FOCUSfactor and Flat Tummy. FOCUSfactor is a brain health supplement brand. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. The company has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications.
The current stock price of SNYR is 1.83 USD. The price increased by 1.67% in the last trading session.
SNYR does not pay a dividend.
SNYR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
SYNERGY CHC CORP (SNYR) has a market capitalization of 20.59M USD. This makes SNYR a Nano Cap stock.
SYNERGY CHC CORP (SNYR) will report earnings on 2026-03-30.
ChartMill assigns a fundamental rating of 4 / 10 to SNYR. SNYR has an average financial health and profitability rating.
Over the last trailing twelve months SNYR reported a non-GAAP Earnings per Share(EPS) of 0.29. The EPS decreased by -67.6% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.46% | ||
| ROA | 12.47% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
7 analysts have analysed SNYR and the average price target is 7.14 USD. This implies a price increase of 290.16% is expected in the next year compared to the current price of 1.83.
For the next year, analysts expect an EPS growth of -25% and a revenue growth 0.72% for SNYR